Metabolic syndrome, ESRD, and death in CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 6, 2013, Pages 945-952

  Navaneethan, Sankar D ^a,b   Schold, Jesse D ^a   Kirwan, John P ^a   Arrigain, Susana ^a   Jolly, Stacey E ^a   Poggio, Emilio D ^a   Beddhu, Srinivasan ^c   Nally, Joseph V ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEATH; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PROTEINURIA; RISK;

EID: 84878849452     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09870912     Document Type: Article

References (38)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Mozumdar A, Liguori G: Persistent increase of prevalence of metabolic syndrome among U.S. adults:NHANES III toNHANES 1999-2006. Diabetes Care 34: 216-219, 2011
3. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 119: 812- 819, 2006
4. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J AmColl Cardiol 49: 403-414, 2007
5. Wu SH, Liu Z, Ho SC: Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. Eur J Epidemiol 25: 375-384, 2010
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285: 2486- 2497, 2001
7. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Available at: http://whqlibdoc.who.int/hq/ 1999/WHO_NCD_NCS_99.2.pdf. Accessed January 28, 2011
8. The International Diabetes Federation ConsensusWorldwide Definition of theMetabolic Syndrome.Available at: http://www.idf.org/ webdata/docs/IDF_Meta_def_final.pdf. Accessed January 28, 2011
9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120: 1640-1645, 2009
10. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004
11. Locatelli F, Pozzoni P, Del Vecchio L: Renalmanifestations in the metabolic syndrome. J Am Soc Nephrol 17[Suppl 2]: S81-S85, 2006
12. Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK: Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am J Kidney Dis 53: 751-759, 2009
13. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373, 2011
14. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W; AASK Study Investigators: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 51: 732-740, 2008
15. Lee CC, Sun CY, Wu IW, Wang SY, Wu MS: Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression-a paradoxical phenomenon. Clin Nephrol 75: 141-149, 2011.
16. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ Jr, Jain A, Nally J.V Jr: Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol 6: 40-49, 2011
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
18. Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A, Rader DJ, Reilly MP, Teal V, Teff K, Wright JT, Xie D: Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol 33: 477-484, 2011
19. The Microalbuminuria Collaborative Study Group: Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: A seven-year prospective study. Diabet Med 16: 918-925, 1999
20. Umegaki H, Haimoto H, Hoshide S, Kario K: Strong association between insulin resistance with urinary albumin excretion in older adults. J Am Geriatr Soc 59: 1361-1362, 2011
21. Conway BR, Rennie J, Bailey MA, Dunbar DR, Manning JR, Bellamy CO, Hughes J, Mullins JJ: Hyperglycemia and renindependent hypertension synergize to model diabetic nephropathy. J Am Soc Nephrol 23: 405-411, 2012
22. Simons JL, Provoost AP, Anderson S, Troy JL, Rennke HG, Sandstrom DJ, Brenner BM: Pathogenesis of glomerular injury in the fawn-hooded rat: Early glomerular capillary hypertension predicts glomerular sclerosis. J Am Soc Nephrol 3: 1775-1782, 1993
23. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM: Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J AmSoc Nephrol 13: 1626-1634, 2002
24. Lee PH, Chang HY, Tung CW, Hsu YC, Lei CC, Chang HH, Yang HF, Lu LC, Jong MC, Chen CY, Fang KY, Chao YS, Shih YH, Lin CL: Hypertriglyceridemia: An independent risk factor of chronic kidney disease in Taiwanese adults. Am JMed Sci 338: 185-189, 2009
25. Muntner P, He J, Astor BC, Folsom AR, Coresh J: Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16: 529-538, 2005
26. Hanai K, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Bouchi R, Tanaka N, Ishii A, Iwamoto Y: Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Nephrol Dial Transplant 27: 1070-1075, 2012
27. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr: Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant 27: 3228-3234, 2012
28. DeGoma EM, Leeper NJ, Heidenreich PA: Clinical significance of high-density lipoprotein cholesterol in patients with low lowdensity lipoprotein cholesterol. J Am Coll Cardiol 51: 49-55, 2008
29. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes- Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W; AIMHIGH Investigators: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.NEngl J Med 365: 2255- 2267, 2011
30. Wahba IM, Mak RH: Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2: 550-562, 2007
31. Kramer H, Shoham D, McClure LA, Durazo-Arvizu R, Howard G, Judd S, Muntner P, Safford M, Warnock DG, McClellan W: Association of waist circumference and body mass index with allcause mortality in CKD: The REGARDS (Reasons for Geographic and RacialDifferences in Stroke) Study. AmJ Kidney Dis 58: 177- 185, 2011
32. Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, Kalantar-Zadeh K, Molnar MZ, Mucsi I: Body mass index, waist circumference andmortality in kidney transplant recipients.AmJ Transplant 10: 2644-2651, 2010
33. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR, Schold JD: Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond) 36: 1585-1590, 2012
34. Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T: Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol 4: 1901-1906, 2009
35. Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM: Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Med Sci Sports Exerc 43: 1457-1464, 2011
36. Afshinnia F, Wilt TJ, Duval S, Esmaeili A, Ibrahim HN: Weight loss and proteinuria: Systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 25: 1173-1183, 2010
37. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S: Weight loss interventions in chronic kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 4: 1565-1574, 2009
38. Heiwe S, Jacobson SH: Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev 10: CD003236, 2011